HUAKANG(605077)

Search documents
华康股份(605077) - 华康股份2025年第二次临时股东大会会议资料
2025-08-26 07:59
浙江华康药业股份有限公司 2025 年第二次临时股东大会 会议材料 二○二五年九月 2025 年第二次临时股东大会 浙江华康药业股份有限公司 2025 年第二次临时股东大会会议须知 一、公司负责本次股东大会的议程安排和会务工作,出席会议人员应当听从 公司工作人员安排,共同维护好会议秩序。 为维护广大投资者的合法权益,保障股东在本次股东大会期间依法行使权 利,根据《公司法》、中国证监会《上市公司股东大会规则》和公司《股东大会 议事规则》等有关规定,特制定本会议须知: 二、为保证股东大会的正常秩序,除出席会议的股东或者股东代理人、董事、 监事、高级管理人员、见证律师及董事会邀请的人员外,公司有权依法拒绝其他 人员进入会场。 三、出席会议的股东须在会议召开前 15 分钟到达会议现场向公司会务人员 办理签到手续,并请按规定出示股票账户卡、持股凭证、身份证或法人单位证明、 授权委托书及出席人身份证等,经验证后领取会议资料,方可出席会议。 四、股东需要在股东大会发言的,应于会议开始前 10 分钟向公司会务人员 进行登记,出示有效的持股证明,填写《发言登记表》;全部股东发言时间控制 在 30 分钟以内,登记后的发言顺序按其 ...
食品饮料ETF天弘(159736)连续5日获资金净流入,实时净申购1200万份,国内消费市场发展态势向好
2 1 Shi Ji Jing Ji Bao Dao· 2025-08-26 02:52
Group 1 - A-shares experienced a decline in most major indices on August 26, with the Tianhong Food and Beverage ETF (159736) showing a slight increase of 0.13% during trading [1] - The Tianhong Food and Beverage ETF has seen a net inflow of funds for five consecutive days, accumulating 86.54 million yuan, with a net inflow of 9.03 million yuan on the previous day [1] - The ETF closely tracks the CSI Food and Beverage Index, which includes major companies in the beverage, packaged food, and meat sectors, with top holdings including Kweichow Moutai, Yili, and Wuliangye [1] Group 2 - In the first half of 2025, China's retail sales of consumer goods reached 24.55 trillion yuan, a year-on-year increase of 5.0%, with restaurant revenue at 2.75 trillion yuan, up 4.3% [2] - Among 231 listed companies in the food and beverage sector, 82 have reported their first-half 2025 earnings, with total revenue of 550.84 billion yuan, a 7.12% increase year-on-year, and net profit of 82.13 billion yuan, up 15.30% [2] - The overall trend in the food and beverage industry indicates stable growth in both revenue and profit, with a focus on the performance of snack brands and the recovery of consumer confidence [2]
代糖概念股震荡拉升,中化国际涨停
Mei Ri Jing Ji Xin Wen· 2025-08-26 02:51
Group 1 - The core viewpoint of the article highlights a significant surge in the sugar substitute concept stocks, with notable performances from several companies [1] Group 2 - Zhonghua International experienced a limit-up increase in its stock price [1] - Baolingbao saw an increase of over 5% in its stock price [1] - Huakang Co., Bailong Chuangyuan, and Xinghuo Technology also experienced upward movements in their stock prices [1]
代糖概念股震荡拉升,中化国际触及涨停
Xin Lang Cai Jing· 2025-08-26 02:04
Group 1 - The concept stocks related to sugar substitutes experienced significant fluctuations, with Zhonghua International hitting the daily limit increase [1] - Baolingbao saw an increase of over 5%, indicating strong market interest [1] - Other companies such as Huakang Co., Bailong Chuangyuan, and Xinghuo Technology also followed suit with upward movements in their stock prices [1]
华康股份2025年中报简析:增收不增利,应收账款上升
Zheng Quan Zhi Xing· 2025-08-22 22:17
据证券之星公开数据整理,近期华康股份(605077)发布2025年中报。截至本报告期末,公司营业总收 入18.66亿元,同比上升37.32%,归母净利润1.34亿元,同比下降3.38%。按单季度数据看,第二季度营 业总收入10.49亿元,同比上升44.95%,第二季度归母净利润5266.77万元,同比下降9.79%。本报告期 华康股份应收账款上升,应收账款同比增幅达39.68%。 本次财报公布的各项数据指标表现一般。其中,毛利率17.8%,同比减17.74%,净利率7.24%,同比减 29.0%,销售费用、管理费用、财务费用总计1.23亿元,三费占营收比6.58%,同比减1.61%,每股净资 产10.01元,同比增5.82%,每股经营性现金流0.27元,同比增248.67%,每股收益0.45元,同比减2.17% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 13.59亿 | 18.66亿 | 37.32% | | 归母浄利润(元) | 1.38 Z | 1.34亿 | -3.38% | | 扣非净利润(元) | ...
8月22日晚间重要公告一览
Xi Niu Cai Jing· 2025-08-22 10:13
Group 1 - Gujia Home achieved a net profit of 1.02 billion yuan in the first half of 2025, a year-on-year increase of 13.89% [1] - Gujia Home's revenue for the first half of 2025 was 9.80 billion yuan, up 10.02% year-on-year [1] - Phoenix Holdings reported a net profit of 11.04 million yuan, successfully turning a profit [1] - Phoenix Holdings' revenue increased by 200.78% year-on-year to 291 million yuan [1] - Zheshang Securities recorded a net profit of 1.15 billion yuan, a year-on-year growth of 46.49% [1] - Zheshang Securities' revenue decreased by 23.66% to 6.11 billion yuan [1] Group 2 - Tianjin Port's net profit was 503 million yuan, a year-on-year decrease of 18.33% [3] - Tianjin Port's revenue for the first half of 2025 was 6.18 billion yuan, an increase of 4.33% year-on-year [3] - Xuantai Pharmaceutical reported a net profit of 45.59 million yuan, down 15.82% year-on-year [5] - Xuantai Pharmaceutical's revenue was 220 million yuan, a slight increase of 0.74% year-on-year [5] Group 3 - Yilida achieved a net profit of 40.03 million yuan, a year-on-year increase of 18.32% [7] - Yilida's revenue for the first half of 2025 was 758 million yuan, up 12.56% year-on-year [7] - Zhongji United reported a net profit of 262 million yuan, a significant year-on-year increase of 86.61% [9] - Zhongji United's revenue was 818 million yuan, a year-on-year growth of 43.52% [9] Group 4 - China Shipbuilding Special Gas reported a net profit of 178 million yuan, a slight decrease of 0.55% year-on-year [10] - China Shipbuilding Special Gas' revenue was 1.04 billion yuan, an increase of 12.60% year-on-year [10] - Xinyuan Intelligent Manufacturing achieved a net profit of 9.79 million yuan, a year-on-year increase of 284.45% [11] - Xinyuan Intelligent Manufacturing's revenue was 329 million yuan, up 388.33% year-on-year [11] Group 5 - Jiudian Pharmaceutical reported a net profit of 291 million yuan, a year-on-year increase of 2.57% [13] - Jiudian Pharmaceutical's revenue was 1.51 billion yuan, a year-on-year growth of 10.67% [13] - Boya Biological reported a net profit of 225 million yuan, down 28.68% year-on-year [15] - Boya Biological's revenue was 1.01 billion yuan, an increase of 12.51% year-on-year [15] Group 6 - True Love Home achieved a net profit of 197 million yuan, a year-on-year increase of 484.48% [17] - True Love Home's revenue was 390 million yuan, up 21.82% year-on-year [17] - Dongfang Electronics reported a net profit of 302 million yuan, a year-on-year increase of 19.65% [19] - Dongfang Electronics' revenue was 3.16 billion yuan, a year-on-year growth of 12.18% [19] Group 7 - Watte Holdings achieved a net profit of 18.41 million yuan, a year-on-year increase of 23.94% [21] - Watte Holdings' revenue was 906 million yuan, up 12.29% year-on-year [21] - Tianqin Equipment reported a net profit of 16.36 million yuan, a year-on-year increase of 2.78% [22] - Tianqin Equipment's revenue was 111 million yuan, a year-on-year growth of 18.42% [22] Group 8 - Yingfeng Environment achieved a net profit of 382 million yuan, a year-on-year increase of 0.43% [24] - Yingfeng Environment's revenue was 6.46 billion yuan, up 3.69% year-on-year [24] - Kexin Machinery reported a net profit of 52.20 million yuan, a year-on-year decrease of 46.18% [26] - Kexin Machinery's revenue was 592 million yuan, down 17.26% year-on-year [26] Group 9 - Tengda Construction reported a net profit of 108 million yuan, a year-on-year decrease of 0.69% [27] - Tengda Construction's revenue was 1.61 billion yuan, down 5.20% year-on-year [27] - Canaan Technology achieved a net profit of 7.35 million yuan, a year-on-year decrease of 38.46% [29] - Canaan Technology's revenue was 560 million yuan, up 1.29% year-on-year [29] Group 10 - Metro Design reported a net profit of 221 million yuan, a year-on-year increase of 6.58% [30] - Metro Design's revenue was 1.32 billion yuan, up 5.31% year-on-year [30] - China Shipbuilding Special Gas plans to use up to 2.9 billion yuan of idle funds for cash management [31] - The company intends to invest in safe, liquid, principal-protected products [31] Group 11 - Jiuchuang Biotechnology received a medical device registration certificate for its lupus anticoagulant detection kit [32] - The product is intended for in vitro qualitative detection of lupus anticoagulant in human plasma [32] - Xinowei's subsidiary received approval for clinical trials of its innovative drug [33] - The drug is a humanized monoclonal antibody intended for treating multiple cancers [33] Group 12 - Dongcheng Pharmaceutical's subsidiary received FDA approval for clinical trials of its targeted radiopharmaceutical [34] - The drug is intended for treating advanced prostate cancer [34] - Shandong Road and Bridge received approval to issue bonds up to 4 billion yuan [35] - The company specializes in road and bridge engineering construction [35] Group 13 - Diou Home plans to invest 500 million yuan to establish a subsidiary focused on generative AI [36] - The investment aims to transform the company into a full-stack industrial intelligent service provider [36] - Dayilong achieved a net profit of 90.87 million yuan, a year-on-year increase of 217.89% [37] - Dayilong's revenue was 957 million yuan, up 57.35% year-on-year [37] Group 14 - Chaohongji reported a net profit of 331 million yuan, a year-on-year increase of 44.34% [38] - Chaohongji's revenue was 4.10 billion yuan, up 19.54% year-on-year [38] - Taiji Group reported a net profit of 139 million yuan, a year-on-year decrease of 71.94% [39] - Taiji Group's revenue was 5.66 billion yuan, down 27.63% year-on-year [39] Group 15 - Suneng Co. reported a net profit of 93.19 million yuan, a year-on-year decrease of 90.13% [41] - Suneng Co.'s revenue was 5.57 billion yuan, down 17.15% year-on-year [41] - Three Gorges Water Conservancy reported a net profit of 47.93 million yuan, a year-on-year decrease of 79.07% [42] - Three Gorges Water Conservancy's revenue was 4.90 billion yuan, down 6.10% year-on-year [42] Group 16 - Furida reported a net profit of 108 million yuan, a year-on-year decrease of 15.16% [44] - Furida's revenue was 1.79 billion yuan, down 7.05% year-on-year [44] - Chenzhou Electric International achieved a net profit of 25.92 million yuan, a year-on-year increase of 29.55% [46] - Chenzhou Electric International's revenue was 1.96 billion yuan, up 1.26% year-on-year [46] Group 17 - Farlantek achieved a net profit of 122 million yuan, a year-on-year increase of 41.05% [47] - Farlantek's revenue was 1.18 billion yuan, up 46.63% year-on-year [47] - Huitai Medical reported a net profit of 425 million yuan, a year-on-year increase of 24.11% [48] - Huitai Medical's revenue was 1.21 billion yuan, up 21.26% year-on-year [48] Group 18 - Dameng Data's director is under investigation for suspected violations [49] - The company's daily operations remain normal [49] - Maiwei Co. reported a net profit of 394 million yuan, a year-on-year decrease of 14.59% [50] - Maiwei Co.'s revenue was 4.21 billion yuan, down 13.48% year-on-year [50] Group 19 - Waiservice Holdings achieved a net profit of 384 million yuan, a year-on-year increase of 5.51% [52] - Waiservice Holdings' revenue was 12.25 billion yuan, up 16.15% year-on-year [52] - Huakang Co. reported a net profit of 134 million yuan, a year-on-year decrease of 3.38% [53] - Huakang Co.'s revenue was 1.87 billion yuan, up 37.32% year-on-year [53] Group 20 - Bluelight Optical achieved a net profit of 103 million yuan, a year-on-year increase of 110.27% [54] - Bluelight Optical's revenue was 577 million yuan, up 52.54% year-on-year [54] - Shunwang Technology reported a net profit of 162 million yuan, a year-on-year increase of 69.22% [55] - Shunwang Technology's revenue was 1.01 billion yuan, up 25.09% year-on-year [55] Group 21 - Anbiping reported a net loss of 12.50 million yuan in the first half of 2025 [56] - Anbiping's revenue was 159 million yuan, down 30.11% year-on-year [56] - Jinhua Co. reported a net profit of 6.20 million yuan, a year-on-year decrease of 34.53% [57] - Jinhua Co.'s revenue was 241 million yuan, down 1.90% year-on-year [57] Group 22 - Xiehe Electronics achieved a net profit of 28.96 million yuan, a year-on-year decrease of 8.31% [59] - Xiehe Electronics' revenue was 451 million yuan, up 12.13% year-on-year [59] - Huguang Co. reported a net profit of 276 million yuan, a year-on-year increase of 8.40% [60] - Huguang Co.'s revenue was 3.63 billion yuan, up 6.20% year-on-year [60]
化学制品板块8月22日涨0.83%,雪峰科技领涨,主力资金净流出5.81亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-22 08:32
| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603227 | 雪峰科技 | 9.79 | 10.00% | 107.06万 | 10.28亿 | | 300225 | *ST全泰 | 5.15 | 9.11% | 50.17万 | 2.56亿 | | 301617 | 博苑股份 | 48.70 | 8.61% | 12.66万 | 5.98亿 | | 600160 | 巨化股份 | 33.00 | 5.40% | 63.41万 | 20.53亿 | | 688398 | 赛特新材 | 21.74 | 4.72% | 5.90万 | 1.28亿 | | 688269 | 凯立新材 | 39.96 | 4.09% | 3.94万 | 1.56亿 | | 688129 | 东来技术 | 25.59 | 3.73% | 2.71万 | 6969.02万 | | 603110 | 东方材料 | 16.69 | 3.66% | 25.13万 | 4.16亿 | | 605077 | 华康股份 | 18. ...
国信证券发布华康股份研报,2025年上半年业绩承压,静待舟山产能持续爬坡
Mei Ri Jing Ji Xin Wen· 2025-08-22 02:57
Group 1 - The core viewpoint of the report is that Guokang Co., Ltd. (605077.SH) is rated as "better than market" due to its expected performance and strategic moves [2] - The company's net profit attributable to shareholders is projected to decline by 3.38% year-on-year in the first half of 2025, primarily due to increased depreciation from the Zhoushan Huakang Project's first phase capacity conversion [2] - The orderly commissioning of new capacity in Zhoushan is expected to significantly boost the company's performance [2] - The company plans to acquire Yuxin Sugar Alcohol through cash and equity, which will strengthen its leading position in the xylitol industry [2]
华康股份(605077):2025年上半年业绩承压,静待舟山产能持续爬坡
Guoxin Securities· 2025-08-22 01:30
Investment Rating - The investment rating for Huakang Co., Ltd. is "Outperform the Market" [4][6][24] Core Views - The company experienced a 3.38% year-on-year decline in net profit attributable to shareholders in the first half of 2025, primarily due to increased depreciation from the Zhoushan project [1][9] - The company achieved a revenue of 1.866 billion yuan in the first half of 2025, representing a 37.32% year-on-year growth [1][9] - The new production capacity in Zhoushan is expected to significantly boost the company's performance as it gradually comes online [2][4] - The acquisition of Yuxin Sugar Alcohol is aimed at consolidating the company's leading position in the xylitol industry, with a transaction value of 1.098 billion yuan [3][18] Summary by Sections Financial Performance - In the first half of 2025, the company reported a revenue of 1.866 billion yuan, a 37.32% increase year-on-year, while the net profit attributable to shareholders was 134 million yuan, down 3.38% [1][9] - The second quarter of 2025 saw revenues of 1.049 billion yuan, a 44.95% increase year-on-year, but net profit decreased by 9.79% year-on-year [1][9] Production Capacity and Projects - The Zhoushan "200,000 tons corn deep processing health food ingredients project" is being developed in two phases, with the first phase nearing completion [2][4] - The first phase of the project focuses on liquid syrup and some crystalline sugar alcohol products, while the second phase will introduce dietary fibers and modified starches [2] Acquisition Strategy - The company plans to acquire 100% of Yuxin Sugar Alcohol through a combination of cash and stock, with the acquisition expected to enhance its market position in xylitol [3][18] - Post-acquisition, the company’s domestic production capacity in xylitol is projected to exceed 50% [3][18] Future Outlook - The company is expected to maintain a growth trajectory over the next five years, driven by new production capacities and strategic acquisitions [4][23] - Revenue projections for the next three years are adjusted to 4.161 billion yuan, 5.482 billion yuan, and 6.304 billion yuan, respectively [4][23]
浙江华康药业股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-21 20:17
Core Viewpoint - The company plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, amounting to approximately 60.61 million yuan, based on the total share capital as of August 20, 2025 [3] Group 1: Company Overview - The company is named Zhejiang Huakang Pharmaceutical Co., Ltd. and is identified by the stock code 605077 [6] - The company has undergone changes in its governance structure, including the cancellation of the supervisory board, with its responsibilities being transferred to the audit committee of the board [14][16] Group 2: Financial Data - The company reported that its revenue is expected to increase in 2025 due to the commencement of production lines for the "1 million tons corn deep processing health food ingredient project" and the acquisition of a wholly-owned subsidiary [5] - The total number of shares has increased from 303,048,234 to 303,049,751 due to the conversion of convertible bonds, resulting in a slight increase in registered capital [15][16] Group 3: Board Meeting Resolutions - The board of directors held a meeting on August 21, 2025, where several key resolutions were passed, including the approval of the 2025 semi-annual report and the profit distribution plan [8][9] - The board also approved the proposal to cancel the supervisory board and amend the company's articles of association, which will be submitted for shareholder approval [9][10][14]